NCT04958174

Brief Summary

The detection of developmental disorders in the child is often late because the parents do not have the information necessary to consult at the first clinical signs. For example, the diagnosis of autism spectrum disorders is made at the age of 5, so earlier diagnoses are possible earlier or even in the 1st year with appropriate questionnaires. An application (Malo) has been developed to allow through regular questionnaires from 1 month to 3 years old to assess the child's development by his parents in the form of a digital health record assessing several areas at regular intervals (monthly the 1st year then every 3 to 12 months): sensory, psychomotor development, sleep, height and weight, cognitive and addictions (especially to screens). The questions will be adapted to the age of the child. An alert suggesting to consult the general practitioner or the pediatrician will be generated according to an algorithm validated by a committee of experts. Based on a study model on health data already carried out as part of the triage application for patients suspected of COVID 19 coronavirus disease.fr with 14 million users in 6 months having improved the relevance of calls to the 15 (8 times fewer unnecessary calls) and general practitioners. This study will assess parental interest in this application.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 12, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

August 15, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2023

Completed
Last Updated

December 20, 2021

Status Verified

June 1, 2021

Enrollment Period

1.5 years

First QC Date

June 29, 2021

Last Update Submit

December 3, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • usefulness

    number of users who find the application useful

    6 months

Secondary Outcomes (3)

  • Alert

    6 months

  • Consultation

    6 months

  • postpartum depression

    6 months

Study Arms (1)

Users

Users of the web-application

Device: web-application

Interventions

web application for monitoring children's development

Also known as: MALO
Users

Eligibility Criteria

Age1 Month - 3 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The application will be made available to Sarthois after a launch campaign by local media for parents with children aged 1 month to 3 years. The population will include the first 180 users of the application who did not object to the use of their data for this assessment.

You may qualify if:

  • Parent of a child or more under 3 years of age (1 month to 3 years)

You may not qualify if:

  • Parent of a child who has already been diagnosed with a developmental disorder, known physical or mental disability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ILC

Le Mans, 72000, France

RECRUITING

Related Publications (1)

  • Denis F, Maurier L, Carillo K, Ologeanu-Taddei R, Septans AL, Gepner A, Le Goff F, Desbois M, Demurger B, Silber D, Zeitoun JD, Assuied GP, Bonnot O. Early Detection of Neurodevelopmental Disorders of Toddlers and Postnatal Depression by Mobile Health App: Observational Cross-sectional Study. JMIR Mhealth Uhealth. 2022 May 16;10(5):e38181. doi: 10.2196/38181.

Study Officials

  • Fabrice DENIS, Pr

    Weprom

    STUDY DIRECTOR

Central Study Contacts

Magali BALAVOINE

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2021

First Posted

July 12, 2021

Study Start

August 15, 2021

Primary Completion

February 15, 2023

Study Completion

February 15, 2023

Last Updated

December 20, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations